These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


82 related items for PubMed ID: 1397570

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Expression of c-myc and c-fos in rat skeletal muscle. Evidence for increased levels of c-myc mRNA during hypertrophy.
    Whitelaw PF, Hesketh JE.
    Biochem J; 1992 Jan 01; 281 ( Pt 1)(Pt 1):143-7. PubMed ID: 1731749
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Transforming growth factor betas are upregulated in the rat masseter muscle hypertrophied by clenbuterol, a beta2 adrenergic agonist.
    Akutsu S, Shimada A, Yamane A.
    Br J Pharmacol; 2006 Feb 01; 147(4):412-21. PubMed ID: 16402040
    [Abstract] [Full Text] [Related]

  • 25. Anabolic beta-2-agonist clenbuterol fails to modify muscle atrophy due to femur fracture.
    Choo JJ, Horan MA, Little RA, Rothwell NJ, Wareham A.
    Circ Shock; 1990 Oct 01; 32(2):165-71. PubMed ID: 1701362
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Molecular impact of clenbuterol and isometric strength training on rat EDL muscles.
    Mounier R, Cavalié H, Lac G, Clottes E.
    Pflugers Arch; 2007 Jan 01; 453(4):497-507. PubMed ID: 17093970
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clenbuterol mimics effects of innervation on myogenic regulatory factor expression.
    Maltin CA, Delday MI, Campbell GP, Hesketh JE.
    Am J Physiol; 1993 Jul 01; 265(1 Pt 1):E176-8. PubMed ID: 8393291
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of thyroid hormone on uncoupling protein-3 mRNA expression in rat heart and skeletal muscle.
    Queiroz MS, Shao Y, Ismail-Beigi F.
    Thyroid; 2004 Mar 01; 14(3):177-85. PubMed ID: 15072699
    [Abstract] [Full Text] [Related]

  • 32. Modulating influence of D,L-propranolol on triiodothyronine-induced skeletal muscle protein degradation.
    Miller JL, Ismail F, Waligora JK, Gevers W.
    Endocrinology; 1985 Sep 01; 117(3):869-71. PubMed ID: 4017966
    [Abstract] [Full Text] [Related]

  • 33. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol.
    Kline WO, Panaro FJ, Yang H, Bodine SC.
    J Appl Physiol (1985); 2007 Feb 01; 102(2):740-7. PubMed ID: 17068216
    [Abstract] [Full Text] [Related]

  • 34. The effects of intraperitoneal clenbuterol injection on protein degradation and myostatin expression differ between the sartorius and pectoral muscles of neonatal chicks.
    Ijiri D, Ishitani K, Shimamoto S, Ishimaru Y, Ohtsuka A.
    Gen Comp Endocrinol; 2014 Sep 15; 206():111-7. PubMed ID: 25117456
    [Abstract] [Full Text] [Related]

  • 35. Effects on meat quality of the use of clenbuterol in veal calves.
    Geesink GH, Smulders FJ, van Laack HL, van der Kolk JH, Wensing T, Breukink HJ.
    J Anim Sci; 1993 May 15; 71(5):1161-70. PubMed ID: 8505249
    [Abstract] [Full Text] [Related]

  • 36. Transcriptional regulation of decreased protein synthesis during skeletal muscle unloading.
    Howard G, Steffen JM, Geoghegan TE.
    J Appl Physiol (1985); 1989 Mar 15; 66(3):1093-8. PubMed ID: 2708233
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Satellite cells in innervated and denervated muscles treated with clenbuterol.
    Maltin CA, Delday MI.
    Muscle Nerve; 1992 Aug 15; 15(8):919-25. PubMed ID: 1495507
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.